Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenomics, Northwestern U, Collaborate on Cancer Testing

NEW YORK (GenomeWeb) – NeoGenomics today announced it has entered into a research agreement with Northwestern University's Robert H. Lurie Comprehensive Cancer Center and the Northwestern Medicine Developmental Therapeutics Institute. The partners will start a large translational program to establish the clinical utility of comprehensive genomic profiling technologies throughout the development of cancer therapies.

Research will focus on individualized patient care and will include a broad range of studies to expand current protocols focused on matching tumor genome profiles identified by the firm's NeoType cancer profiling tests with investigational therapies.

"We need to perform appropriate molecular analyses on all possible patient tumors. NeoGenomics is a key ally in NMDTI's focus on individualized patient care with cognate therapies directed at key molecular targets in cancer," NMDTI Director Francis Giles said in a statement.

"Working with NMDTI, we will explore how our NeoType cancer profiles can help guide clinicians in selecting the precise therapeutic approach for treating specific cancers in order to improve outcomes," NeoGenomics Chief Medical Officer Maher Albitar said.

In November, the Lurie Cancer Center and NMDTI signed a research agreement with Foundation Medicine to develop cancer profiling technologies.

Financial and other details of the agreement were not disclosed.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.